Pune Health Briefing: Indian Pharmaceutical Alliance to host 7th Global Pharmaceutical Quality Summit
The Indian Pharmaceutical Alliance (IPA) is ready to host the seventh edition of the “Global Pharmaceutical Quality Summit (GPQS)” virtually. This year’s theme is “Making Quality Pharmaceuticals in India, Sustainably, for the World” and is scheduled to be held from February 24-25. The forum aims to bring together manufacturers and regulators on a common platform to facilitate discussions leading to meaningful and actionable quality results. The summit will bring together over 30 global leaders and regulators taking part in 15 sessions covering key aspects of manufacturing and quality from a sustainability perspective.
The conference will begin with a keynote address by S Aparna, Secretary of the Department of Pharmaceuticals, and a special address by Dr VG Somani, Comptroller General of Medicines of India. The two-day summit will feature technical sessions, panel discussions and special addresses from global subject matter experts on topics including quality excellence in pharmaceutical operations, vaccine development and lessons learned about quality excellence from other industries, among others. The closing session will feature a panel discussion of CEOs from major Indian pharmaceutical companies such as Cadila, Cipla, Dr. Reddy’s, Lupin, Sun Pharma and Torrent Pharma to deliberate on “End-to-End Sustainable Operations and Quality Excellence “.
Pfizer’s support for the Tata Trusts Cancer Care program
Pfizer announced that its support of the Tata Trusts Cancer Care program since 2020 has helped recruit and screen 70,000 people for non-communicable diseases (NCDs) and cancer in Assam, Jharkhand and Andhra Pradesh. Pfizer has partnered with Tata Trusts special purpose vehicle, Alamelu Charitable Foundation (ACF), for its cancer care program to help set up health and wellness kiosks, facilitate the community screening and a virtual patient support desk, and to assist in the training of ASHA and Anganwadi workers in Diphu and Silchar in Assam and further in Ranchi, Jharkhand and Tirupati, Andhra Pradesh . Assam has one of the highest rates of new cancer cases in India. The goal of the partnership is to help reduce the heavy burden of cancer by raising awareness, aiding in the early detection of cancer and, through several programs, serving the public, patients and caregivers throughout the cancer journey. cancer treatment.
In a statement, S Sridhar, chief executive of Pfizer Limited, said: “Innovative and life-saving therapies are the foundation of modern cancer care, and yet care must begin with reducing exposure to risk factors. modifiable, large-scale screening to aid in early detection and diagnosis, and support patients throughout their journey. Our partnership with the Tata Trusts Cancer Care Program has helped us to truly support patients from early detection through the continuum of care, to ensure that their treatment outcomes are the best possible.
Dr Sanjiv Chopra, Chief Executive, Cancer Care Programme, Tata Trusts, said: “The Tata Trusts Cancer Care Program envisions interventions along the continuum of care, including awareness raising, technology , financial assistance and a host of other thoughtful and strategic initiatives.